487 filings
Page 5 of 25
CORRESP
t551j 6iam3x079r
17 Mar 23
Correspondence with SEC
12:00am
CORRESP
cjuaylfz
17 Mar 23
Correspondence with SEC
12:00am
F-1/A
89jmlz eea37ku
13 Mar 23
Registration statement (foreign) (amended)
9:18am
CORRESP
c42qxx3swqnriqjp 6g
13 Mar 23
Correspondence with SEC
12:00am
CORRESP
mur0emg
13 Mar 23
Correspondence with SEC
12:00am
FWP
910p8
9 Mar 23
Free writing prospectus
4:31pm
6-K
dcgwx5qkhg2dhfp
9 Mar 23
Current Report
4:30pm
FWP
6dxtz pwz
8 Mar 23
Free writing prospectus
10:10am
F-1/A
thbdxjt42e7zr7d 6u
7 Mar 23
Registration statement (foreign) (amended)
1:02pm
F-1/A
xcsw b0ajuctsmt6jkb
1 Mar 23
Registration statement (foreign) (amended)
1:02pm
F-1/A
15cuq
28 Feb 23
Registration statement (foreign) (amended)
4:12pm
CORRESP
6bupf 8wi60qfu
28 Feb 23
Correspondence with SEC
12:00am
UPLOAD
vgdsxq
24 Feb 23
Letter from SEC
12:00am
6-K
r5odm0agv881swgy8t
17 Feb 23
Report of Foreign Private Issuer
4:30pm
F-1
3geq5yy5gj fm
16 Feb 23
Registration statement (foreign)
10:17am
6-K
cuyju crstjr75j
27 Jan 23
Report of Foreign Private Issuer
8:50am
6-K
jkd1jhr7ltfe5u9pch63
24 Jan 23
Altamira Therapeutics Provides Update on Clinical Trials with Bentrio
9:00am
SC 13D/A
0egb1m
18 Jan 23
Altamira Therapeutics / Meyer Thomas ownership change
4:30pm
424B4
pknzr r3uw
28 Dec 22
Prospectus supplement with pricing info
9:23am
EFFECT
4oguszu bscyb35rh
28 Dec 22
Notice of effectiveness
12:15am